BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20496196)

  • 1. Effects of bicyclol on immunological liver fibrosis in rats.
    Gu Y; Zhao J; Yao XM; Li Y
    J Asian Nat Prod Res; 2010 May; 12(5):388-98. PubMed ID: 20496196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride-induced liver fibrosis in rats.
    Yuan LP; Chen FH; Ling L; Bo H; Chen ZW; Li F; Zhong MM; Xia LJ
    J Pharm Pharmacol; 2008 Oct; 60(10):1393-402. PubMed ID: 18812033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
    Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
    J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB; Li DG; Lu HM
    J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action.
    Hu QW; Liu GT
    Life Sci; 2006 Jul; 79(6):606-12. PubMed ID: 16603200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect.
    Xu L; Zheng N; He Q; Li R; Zhang K; Liang T
    Phytomedicine; 2013 Oct; 20(13):1172-9. PubMed ID: 23856441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
    Yao HW; Li J; Chen JQ; Xu SY
    Acta Pharmacol Sin; 2004 Jul; 25(7):915-20. PubMed ID: 15210065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of matrix metalloproteinase on hepatic transforming growth factor beta1 and caspase-3 activation in hemorrhage.
    Maitra SR; Bhaduri S; El-Maghrabi MR; Shapiro MJ
    Acad Emerg Med; 2005 Sep; 12(9):797-803. PubMed ID: 16141011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
    Xu W; Song S; Huang Y; Gong Z
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats.
    Sun WY; Wei W; Wu L; Gui SY; Wang H
    J Ethnopharmacol; 2007 Jul; 112(3):514-23. PubMed ID: 17574357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of bicyclol on acute alcohol-induced liver injury in mice.
    Zhao J; Chen H; Li Y
    Eur J Pharmacol; 2008 May; 586(1-3):322-31. PubMed ID: 18371952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation.
    Chou WY; Lu CN; Lee TH; Wu CL; Hung KS; Concejero AM; Jawan B; Wang CH
    Acta Pharmacol Sin; 2006 Apr; 27(4):469-76. PubMed ID: 16539848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis.
    Ryu SH; Chung YH; Lee JK; Kim JA; Shin JW; Jang MK; Park NH; Lee HC; Lee YS; Suh DJ
    Liver Int; 2009 Feb; 29(2):308-14. PubMed ID: 18564211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
    Wang H; Li Y
    Eur J Pharmacol; 2006 Mar; 534(1-3):194-201. PubMed ID: 16487963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
    Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of Shaoqiduogan on MMP-13, TIMP-1 expression in liver and hepatic stellate cells of hepatic fibrosis rats].
    Sun W; Gui S; Wu L; Wang H; Wei W
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1447-51. PubMed ID: 20822018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
    Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
    Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
    Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S
    Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.